[Hyperbaric oxygen therapy adjunctive to surgical debridement in management of Fournier's gangrene: usefulness of a severity index score in predicting disease gravity and patient survival]

What Researchers Did

Researchers studied 70 patients with Fournier's gangrene to evaluate the effectiveness of surgical debridement combined with hyperbaric oxygen therapy (HBOT) and the usefulness of a severity index score.

What They Found

Out of 70 patients with Fournier's gangrene treated with surgery and HBOT, 8 (11.4%) died, while 62 (88.5%) survived. The median body surface area affected by the infection was significantly smaller in survivors (2.4%) compared to non-survivors (4.9%). The Fournier's Gangrene Severity Index (FGSI) score did not accurately predict the disease's severity or patient survival.

What This Means for Canadian Patients

For Canadian patients facing Fournier's gangrene, this study suggests that combining hyperbaric oxygen therapy with surgical debridement may improve survival outcomes. While the severity index score was not predictive, the overall survival rate of 88.5% in this group highlights the potential benefit of this combined treatment approach for managing this serious infection.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This study was retrospective and did not include a control group of patients who received only surgical debridement, which limits direct comparison of treatment effectiveness.